General MedicationsORALGeneric
CEPHRADINE
CEPHRADINE
Standard Dose
125MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CEPHRADINE is listed in Drugs@FDA under application 062858 (ANDA).
Marketing status: Discontinued Active ingredient CEPHRADINE Form and strength FOR SUSPENSION;ORAL - 125MG/5ML Sponsor BARR Submission history Latest submission status date: 1998-12-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEPHRADINE is listed in Drugs@FDA under application 062858 (ANDA). Marketing status: Discontinued Active ingredient CEPHRADINE Form and strength FOR SUSPENSION;ORAL - 125MG/5ML Sponsor BARR Submission history Latest submission status date: 1998-12-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.